• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过去二十年炎症性肠病的演变:一项按时间顺序进行的多国研究。

Inflammatory bowel disease evolution in the past two decades: a chronological multinational study.

作者信息

Alavinejad Pezhman, Hashemi Seyed Jalal, Behl Nitin, Hormati Ahmad, Elbasuny Abubakr, Daryani Naser Ebrahimi, Modarres Mehdi Pezeshgi, Arshadzadeh Masoud, Panahande Samira, Hang Dao Viet, Mahros Aya Mohammed, Parsi Abazar, Javaherizadeh Hazhir, Rehman Ata, Pawlak Katarzyna M, Ahmadi Mitra, Ahmed Mohammed Hussien, Farsi Farnaz, Arefi Mohammad, Quadri Afreen, Tran Quang Trung, Alborzi Foroogh, Amin Alavi Seyed Mohammad, Cheraghian Bahman, Ramezani Elmira, Gouda Mohammed Fathi, Saadati Babak, Quadri Ahmed Alam, Hirani Rahim, Maher Maha, Ghoneem Elsayed

机构信息

Alimentary Tract Research Centre, Imam Khomeini Hospital Clinical Research Development Unit, The School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Institute of Gastro and Liver Diseases, Fortis Hospital, Ludhiana, India.

出版信息

EClinicalMedicine. 2024 Mar 15;70:102542. doi: 10.1016/j.eclinm.2024.102542. eCollection 2024 Apr.

DOI:10.1016/j.eclinm.2024.102542
PMID:38525407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10959644/
Abstract

BACKGROUND

The multifactorial nature of inflammatory bowel disease (IBD), which manifests differently in individuals creates a need for a better understanding of the behaviour and pattern of the disease due to environmental factors. The current study aimed to study the changes in IBD behaviour, presentation, and characteristics in patients over the past two decades with a goal of improving patients' diagnosis, management and outcomes.

METHODS

During a 6-month period (1/02/2022-30/07/2022), the information of patients with IBD who attended IBD outpatient clinics of 11 referral centre's in six countries was collected, and based on the first time of diagnosis with IBD, they were allocated as group A (those who were diagnosed more than 15 years ago), group B (those who were diagnosed with IBD between 5 and 15 years ago) and group C (IBD cases who diagnosed in recent 5 years). Then the most prevalent subtypes and characters of the disease are evaluated and compared to make clear if the presenting pattern and behaviour of the disease has changed in the last 2 decades.

FINDINGS

Overall 1430 patients with IBD including 1207 patients with ulcerative colitis (UC) (84.5%) and 205 patients with Crohn's disease (CD; 14.3%) included. Mean age of participants at the first time of diagnosis with IBD was 30 years. The extra-intestinal involvement of IBD in groups A and B was more prevalent in comparison with group C. Most of those in groups A & B had academic education but in group C, the most prevalent educational status was high school or diploma (P = 0.012). In contrast to groups A and B, the relative prevalence of medium socioeconomic level in group C had decreased (65%). Relative prevalence of UC subtypes was similar among groups A and B (extensive colitis as most prevalent) but in group C, the most prevalent subtype is left side colitis (38.17%). The most prevalent subtype of CD in groups A and B was ileocolic involvement while in group C, upper GI involvement is significantly increased. The rate of food sensitivity among groups A and B was more than group C (P = 0.00001). The relative prevalence of patients with no flare has increased with a steady slope (P < 0.00001). Relative prevalence of presenting symptoms among patients with UC in group C differs and nowadays the rate abdominal pain (70.7%) and bloating (43.9%) have increased and frequency of diarrhoea (67.4%) has decreased.

INTERPRETATION

In the recent 5 years, the pattern of UC presentation has changed. The rate of upper GI involvement in CD and relative prevalence of patients with no disease flare increased and the rate of extra intestinal involvement decreased.

FUNDING

None.

摘要

背景

炎症性肠病(IBD)具有多因素性质,在个体中的表现各异,这就需要更好地了解环境因素导致的该疾病的行为和模式。本研究旨在探讨过去二十年来IBD患者的病情行为、表现和特征的变化,以期改善患者的诊断、管理和治疗结果。

方法

在6个月期间(2022年2月1日至2022年7月30日),收集了六个国家11个转诊中心IBD门诊就诊的IBD患者信息,并根据首次诊断为IBD的时间,将他们分为A组(15年以前诊断的患者)、B组(5至15年前诊断为IBD的患者)和C组(最近5年诊断的IBD病例)。然后评估并比较该疾病最常见的亚型和特征,以明确该疾病的表现模式和行为在过去20年中是否发生了变化。

研究结果

共纳入1430例IBD患者,其中1207例为溃疡性结肠炎(UC)患者(84.5%),205例为克罗恩病(CD)患者(14.3%)。参与者首次诊断为IBD时的平均年龄为30岁。与C组相比,A组和B组IBD的肠外受累更为普遍。A组和B组中的大多数人接受过学术教育,但在C组中,最普遍的教育程度是高中或文凭(P = 0.012)。与A组和B组相比,C组中社会经济水平中等的相对患病率有所下降(65%)。UC亚型的相对患病率在A组和B组中相似(广泛性结肠炎最为普遍),但在C组中,最普遍的亚型是左侧结肠炎(38.17%)。A组和B组中CD最常见的亚型是回结肠受累,而在C组中,上消化道受累显著增加。A组和B组的食物敏感率高于C组(P = 0.00001)。无疾病发作患者的相对患病率呈稳定上升趋势(P < 0.00001)。C组UC患者的症状表现相对患病率有所不同,如今腹痛(70.7%)和腹胀(43.9%)的发生率增加,腹泻频率(67.4%)下降。

解读

在最近5年中,UC的表现模式发生了变化。CD中上消化道受累的发生率和无疾病发作患者的相对患病率增加,肠外受累率下降。

资金来源

无。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/0cb4375a3265/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/12d1393f3774/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/9968466de461/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/90ba47bbddd5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/59698d03c3e6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/c85b36ca7cf4/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/0cb4375a3265/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/12d1393f3774/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/9968466de461/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/90ba47bbddd5/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/59698d03c3e6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/c85b36ca7cf4/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9f2/10959644/0cb4375a3265/gr6.jpg

相似文献

1
Inflammatory bowel disease evolution in the past two decades: a chronological multinational study.过去二十年炎症性肠病的演变:一项按时间顺序进行的多国研究。
EClinicalMedicine. 2024 Mar 15;70:102542. doi: 10.1016/j.eclinm.2024.102542. eCollection 2024 Apr.
2
A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.一项针对马来西亚吉隆坡单一三级医疗中心炎症性肠病患者发病率趋势、社会人口学和临床特征的四十年分析。
BMC Public Health. 2019 Jun 13;19(Suppl 4):550. doi: 10.1186/s12889-019-6858-2.
3
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.2018年炎症性肠病对加拿大的影响:直接成本与医疗服务利用情况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.
4
Time Trends of Environmental and Socioeconomic Risk Factors in Patients with Inflammatory Bowel Disease over 40 Years: A Population-Based Inception Cohort 1977-2020.40年来炎症性肠病患者环境和社会经济风险因素的时间趋势:一项基于人群的起始队列研究(1977 - 2020年)
J Clin Med. 2023 Apr 21;12(8):3026. doi: 10.3390/jcm12083026.
5
A Multicentre Study of the Clinical and Epidemiological Profile of Inflammatory Bowel Disease in Northeast Brazil.巴西东北部炎症性肠病临床与流行病学特征的多中心研究
Clin Exp Gastroenterol. 2023 Jun 21;16:87-99. doi: 10.2147/CEG.S411936. eCollection 2023.
6
Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.炎症性肠病:对716名智利当地患者的描述性研究。
World J Gastroenterol. 2016 Jun 14;22(22):5267-75. doi: 10.3748/wjg.v22.i22.5267.
7
Visceral adiposity and inflammatory bowel disease.内脏肥胖与炎症性肠病。
Int J Colorectal Dis. 2021 Nov;36(11):2305-2319. doi: 10.1007/s00384-021-03968-w. Epub 2021 Jun 9.
8
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.《2018年炎症性肠病在加拿大的影响:患有炎症性肠病的儿童和青少年》
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S49-S67. doi: 10.1093/jcag/gwy056. Epub 2018 Nov 2.
9
Patient education interventions for the management of inflammatory bowel disease.炎症性肠病管理的患者教育干预措施。
Cochrane Database Syst Rev. 2023 May 4;5(5):CD013854. doi: 10.1002/14651858.CD013854.pub2.
10
A Study of the Epidemiology, Clinical, and Phenotypic Characteristics of Inflammatory Bowel Disease in the Northen-Central Region of Saudi Arabia.沙特阿拉伯中北部地区炎症性肠病的流行病学、临床及表型特征研究
Diagnostics (Basel). 2023 Jun 21;13(13):2135. doi: 10.3390/diagnostics13132135.

引用本文的文献

1
Microvascular Damage in the Deep Mucosal Triggers the Onset of Colitis in Dextran Sulfate Sodium-induced Colitis in Mice.深层黏膜微血管损伤引发小鼠葡聚糖硫酸钠诱导的结肠炎的发病。
In Vivo. 2025 Jul-Aug;39(4):1864-1878. doi: 10.21873/invivo.13986.
2
Deciphering microbial and metabolic influences in gastrointestinal diseases-unveiling their roles in gastric cancer, colorectal cancer, and inflammatory bowel disease.解读胃肠道疾病中的微生物和代谢影响——揭示它们在胃癌、结直肠癌和炎症性肠病中的作用。
J Transl Med. 2025 May 16;23(1):549. doi: 10.1186/s12967-025-06552-w.
3
Colonic Submucosa Targeted Delivery of Probiotic and Rhein for Ulcerative Colitis Treatment.

本文引用的文献

1
Irritable Bowel Syndrome Demographics: A Middle Eastern Multinational Cross-sectional Study.肠易激综合征人口统计学:一项中东多国横断面研究。
Middle East J Dig Dis. 2022 Apr;14(2):222-228. doi: 10.34172/mejdd.2022.276. Epub 2022 Apr 30.
2
IS DAIRY FOODS RESTRICTION MANDATORY FOR INFLAMMATORY BOWEL DISEASE PATIENTS: A MULTINATIONAL CROSS-SECTIONAL STUDY.乳制品限制是否对炎症性肠病患者强制性:一项多国横断面研究。
Arq Gastroenterol. 2022 Jul-Sep;59(3):358-364. doi: 10.1590/S0004-2803.202203000-65.
3
Natural history of inflammatory bowel disease: a comparison between the East and the West.
用于溃疡性结肠炎治疗的益生菌和大黄素的结肠黏膜下层靶向递送
Adv Sci (Weinh). 2025 Aug;12(30):e2409711. doi: 10.1002/advs.202409711. Epub 2025 May 9.
4
Combining Metagenomics, Network Pharmacology and RNA-Seq Strategies to Reveal the Therapeutic Effects and Mechanisms of Qingchang Wenzhong Decoction on Inflammatory Bowel Disease in Mice.运用宏基因组学、网络药理学和 RNA-Seq 策略揭示清肠温中汤治疗小鼠炎症性肠病的疗效及作用机制。
Drug Des Devel Ther. 2024 Sep 24;18:4273-4289. doi: 10.2147/DDDT.S473688. eCollection 2024.
5
NLRP3 Inflammasome and Gut Dysbiosis Linking Diabetes Mellitus and Inflammatory Bowel Disease.NLRP3炎性小体与肠道微生物群失调:糖尿病与炎症性肠病之间的联系
Arch Intern Med Res. 2024;7(3):200-218. doi: 10.26502/aimr.0178. Epub 2024 Aug 31.
炎症性肠病的自然史:东西方比较
Intest Res. 2022 Oct;20(4):418-430. doi: 10.5217/ir.2021.00104. Epub 2021 Dec 2.
4
Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry.炎症性肠病肠外表现的危险因素——来自罗马尼亚国家登记处的数据。
J Gastrointestin Liver Dis. 2021 Sep 21;30(3):346-357. doi: 10.15403/jgld-3818.
5
Food and Food Groups in Inflammatory Bowel Disease (IBD): The Design of the Groningen Anti-Inflammatory Diet (GrAID).炎症性肠病(IBD)中的食物和食物组:格罗宁根抗炎饮食(GrAID)的设计。
Nutrients. 2021 Mar 25;13(4):1067. doi: 10.3390/nu13041067.
6
Epidemiology of mental health problems in COVID-19: a review.2019冠状病毒病心理健康问题的流行病学:综述
F1000Res. 2020 Jun 23;9:636. doi: 10.12688/f1000research.24457.1. eCollection 2020.
7
Climatic changes and their role in emergence and re-emergence of diseases.气候变化及其在疾病的出现和再现中的作用。
Environ Sci Pollut Res Int. 2020 Jun;27(18):22336-22352. doi: 10.1007/s11356-020-08896-w. Epub 2020 Apr 28.
8
Effect of Lifestyle Factors on Outcomes in Patients With Inflammatory Bowel Diseases.生活方式因素对炎症性肠病患者结局的影响。
Am J Gastroenterol. 2020 Jun;115(6):832-840. doi: 10.14309/ajg.0000000000000608.
9
Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century.改变炎症性肠病的全球流行病学:维持 21 世纪的医疗保健服务。
Clin Gastroenterol Hepatol. 2020 May;18(6):1252-1260. doi: 10.1016/j.cgh.2020.01.028. Epub 2020 Jan 31.
10
A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease.炎症性肠病发病机制的全面综述和更新。
J Immunol Res. 2019 Dec 1;2019:7247238. doi: 10.1155/2019/7247238. eCollection 2019.